Wednesday, November 26, 2014

Synbiota Users Raise Over $3 Million Dollars

Synbiota Users Raise Over $3 Million Dollars After Graduating From Indie Bio Accelerator

Just 18 months after launch, Synbiota Inc's global network of biohackers has produced successful Synthetic Biology startups.

Toronto, Canada (PRWEB) November 12, 2014

Indie Bio and Synbiota have teamed up to offer an exciting 4 month opportunity for those who are willing to take a pioneering leap into Synthetic Biology. The inaugural Summer 2014 cohort was primarily composed of teams from the Synbiota Network and because of their strong applications, great ideas, and hard work, they raised more than $3,000,000 in follow-up funding - Congrats biohackers!

[caption id="attachment_243" align="aligncenter" width="554"]Synbiota Users Raise Over $3 Million Dollars Synbiota Users Raise Over $3 Million Dollars[/caption]

Indie Bio is a wetware accelerator that focuses on entrepreneurs and researchers building technologies in or around the fields of synthetic biology and life science. Indie Bio offers 10 opportunities for $50,000 in seed funding, lab space, as well as mentorship to help take an idea to a product, in exchange for a 8% stake.

Synbiota is a web-based virtual lab that has been designed to support the development of synthetic biology solutions. With an electronic lab book, file storage, team management, IP tracking, metrics, GENtle3; the open-source DNA design tool, and an active community of researchers and enthusiasts spanning the entire globe, Synbiota is an effective R&D platform for individuals or teams of any size.

What Indie Bio graduates are saying about the opportunity:

“Making cow-free milk is not easy," says Ryan Pandya, co-founder of Muufri "but the potential benefits for both humans and cows are undeniable. The Muufri team assembled because of a relationship between New Harvest, Synbiota, and Indie Bio. We were early adopters of Synbiota’s technology and it enabled us to rapidly develop and document our Synthetic Biology R&D, which recently led us to a $2,000,000 investment."

“Synbiota was the first to recognize our talents through BricoBio and invited us to join their online community of biohackers" says Sarah Choukah, co-founder ofHyasynth. "Soon after, with Synbiota we were able to begin development and connect with Indie Bio to get our first round of funding for Hyasynth. We’re now raising additional funds, and Hyasynth is on trajectory to create the world’s first THC producing yeast.”

Apply via Synbiota and link an existing project to increase the chances of being accepted into the program. Showcasing real progress, project organization, and clarity of vision is the best way to secure a position at Indie Bio. Moreover, Synbiota is the primary tool that all members of Indie Bio will use to manage IP and projects throughout the program.

Indie Bio is currently accepting applications for the second cohort, which will run from January 2015 to May 2015 in Silicon Valley. Indie Bio isn’t going to wait until all applications are in to decide on the best applicants. If the Indie Bio team thinks an idea is fundable, they will fund it right away, so the early applicants have a better chance of getting into the program.

Contact indiebio(at)synbiota(dot)com or call 1-87-SYNBIOTA if there are any questions.

Application Deadline for Indie Bio Silicon Valley is December 7th, 2014.

About Synbiota:
Synbiota Inc. was founded in April 2013 in Toronto with the mission to streamline life science R&D and to make it universally accessible. Synbiota was a Fellow of Mozilla Labs, winner of 2014 SXSW Interactive, winner Hacking Health, and winner 48hrs in the Hub. Synbiota is the creator of GENtle the open-source, web-based DNA design tool. Synbiota initiated #ScienceHack, a distributed effort to use Synthetic Biology and Open Science to produce real anti-cancer medicine. Press package.

About Indie Bio:
Indie Bio is the world’s first Synthetic Biology accelerator devoted to funding and building startups dedicated solving humanity’s most pressing problems through biology. Indie Bio funds 4 Synthetic Biology accelerator cohorts per year in both San Francisco, USA., and Cork, Ireland.

Synthetic Biology Market to Reach $5,630 Million by 2018

Synthetic Biology Market Growth Analysis and 2018 Worldwide Forecasts

According to this synthetic biology market report, the industry is expected to reach $5,630.4 Million by 2018 from $1,923.1 Million in 2013, growing at a CAGR of 24% during the forecast period.

DALLAS, November 25, 2014 /PRNewswire/ -- adds Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018 as well as Global Synthetic Biology Market 2014-2018 research reports to the biotechnology intelligence collection of its online library.

[caption id="attachment_239" align="aligncenter" width="650"]Synthetic Biology Market to Reach $5,630 Million by 2018 Synthetic Biology Market to Reach $5,630 Million by 2018[/caption]

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch. The Synthetic Biology Market by Tool, Technology, Application - Global Forecast to 2018 research report says in 2013, the oligo nucleotides segment accounted for the largest share of the global synthetic biology market, by tool, while enabling technologies accounted for the largest share of the synthetic biology market, by technology. The medical application segment accounted for a major share of the synthetic biology applications market in 2013. North America accounted for the largest share of the global synthetic biology market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, Europe is expected to witness the highest growth rate, with emphasis on Germany, U.K., France, Denmark, Switzerland, and Rest of Europe. These countries are expected to serve as revenue pockets for synthetic biology manufacturers.

The global synthetic biology market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market. This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment)for strengthening their market shares.

According to this synthetic biology market report, the industry is expected to reach $5,630.4 Million by 2018 from $1,923.1 Million in 2013, growing at a CAGR of 24% during the forecast period. Companies profiled in this research include Amyris Inc., DuPont, Genscript USA Inc., Intrexon Corporation, Integrated DNA Technologies (IDT) Inc., New England Biolabs Inc., Novozymes, Royal DSM N.V., Synthetic Genomics Inc. and Thermo Fisher Scientific Inc. Order a copy of this research at .

The Global Synthetic Biology Market 2014-2018 research report categorizes the industry on the basis of technology into four segments: Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integrated Systems. The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. This research ( ) forecasts that the Global Synthetic Biology market will grow at a CAGR of 33.8% over the period 2013-2018.

The Global Synthetic Biology Market 2014-2018 report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. It helps answer questions like what will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

Companies active in the synthetic biology market and discussed in this research include Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG: biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM and Synthorx Inc. Order a copy of this report at .

Explore other newly published biotechnology market research reports available with at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Priyank Tiwari / Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441

Connect With Us on:

Facebook:  https: //


Twitter:  https: //

G+ / Google Plus:


RSS/Feeds:  http: //

SOURCE ReportsnReports

News Release Source : Synthetic Biology Market Growth Analysis and 2018 Worldwide Forecasts